Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) announced it has entered into a definitive merger agreement to acquire Kezar Life Sciences, Inc ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE